An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients
Rashin Mohseni, Amir Ali Hamidieh, Alireza Shoae‐Hassani, Masood Ghahvechi-Akbari, Anahita Majma, Mahmoud Mohammadi, Mahin Nikougoftar, Reza Shervin-Badv, Jafar Ai, Hadi Montazerlotfelahi, Mahmoud Reza Ashrafi
Topics & Concepts
MedicinePopulationSpinal muscular atrophyClinical trialAdverse effectNeurologyStem-cell therapySurgeryInternal medicinePediatricsTransplantationDiseasePsychiatryEnvironmental healthNeurogenetic and Muscular Disorders ResearchMuscle Physiology and DisordersSpinal Dysraphism and Malformations